NSE Healthcare Medical - Healthcare Information Services INDGN.NS

Indegene Limited

$ 535.00 3.16 %

Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.

CEO: Manish Gupta - https://www.indegene.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 604.20

Loading data...

INDGN.NS vs S&P500

Loading data...

No data available.

Quick ratio

2.41

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

32.23

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

16.60

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

14.28 %

reflects reasonable profitability, showing good use of equity.

ROIC

10.53 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

7.78

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.05

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

7.79

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

11.97 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
4 indicates moderate financial health
Altman score
6.73 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.35 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.03 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.